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ABSTRACT
Objectives To evaluate the accuracy and probabilities of
different fetal ultrasound parameters to predict neonatal
outcome in isolated congenital diaphragmatic hernia
(CDH).
Methods Between January 2004 and December 2010, we
evaluated prospectively 108 fetuses with isolated CDH
(82 left-sided and 26 right-sided). The following param-
eters were evaluated: gestational age at diagnosis, side
of the diaphragmatic defect, presence of polyhydramnios,
presence of liver herniated into the fetal thorax (liver-
up), lung-to-head ratio (LHR) and observed/expected
LHR (o/e-LHR), observed/expected contralateral and
total fetal lung volume (o/e-ContFLV and o/e-TotFLV)
ratios, ultrasonographic fetal lung volume/fetal weight
ratio (US-FLW), observed/expected contralateral and
main pulmonary artery diameter (o/e-ContPA and o/e-
MPA) ratios and the contralateral vascularization index
(Cont-VI). The outcomes were neonatal death and severe
postnatal pulmonary arterial hypertension (PAH).
Results Neonatal mortality was 64.8% (70/108). Severe
PAH was diagnosed in 68 (63.0%) cases, of which 63
died neonatally (92.6%) (P < 0.001). Gestational age at
diagnosis, side of the defect and polyhydramnios were
not associated with poor outcome (P > 0.05). LHR, o/e-
LHR, liver-up, o/e-ContFLV, o/e-TotFLV, US-FLW, o/e-
ContPA, o/e-MPA and Cont-VI were associated with both
neonatal death and severe postnatal PAH (P < 0.001).
Receiver–operating characteristics curves indicated that
measuring total lung volumes (o/e-TotFLV and US-
FLW) was more accurate than was considering only
the contralateral lung sizes (LHR, o/e-LHR and o/e-
ContFLV; P < 0.05), and Cont-VI was the most accurate
ultrasound parameter to predict neonatal death and severe
PAH (P < 0.001).
Conclusions Evaluating total lung volumes is more
accurate than is measuring only the contralateral lung
size. Evaluating pulmonary vascularization (Cont-VI)
is the most accurate predictor of neonatal outcome.
Estimating the probability of survival and severe PAH
allows classification of cases according to prognosis.
Copyright  2011 ISUOG. Published by John Wiley
& Sons, Ltd.
INTRODUCTION
Neonatal mortality and morbidity in cases with isolated
congenital diaphragmatic hernia (CDH) depend on the
severity of pulmonary hypoplasia and pulmonary arterial
hypertension (PAH), and fetal tracheal occlusion has
been proposed in order to prevent these complications
and therefore to increase neonatal survival1–3. However,
prenatal prediction of those fetuses that will present with
a severe form of CDH at birth is challenging, which
makes it difficult to identify with any precision the best
candidates for fetal intervention. Furthermore, neonatal
mortality rates appear to vary between different centers
all over the world, which may be related to differences in
the standardization of perinatal management, in hidden
mortality, in assessment and in the use of prenatal
intervention4,5. Standard classification of fetuses with
isolated CDH according to prognosis is necessary in order
to determine the best perinatal management and also to
enable better comparison between centers.
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A European group suggested classifying fetuses with
isolated CDH into extremely severe, severe, moderate and
mild forms, based on the observed/expected lung-to-head
ratio (LHR) and the presence of herniated liver in the fetal
thorax6,7. Several fetal parameters have been proposed in
order to predict neonatal outcome in isolated CDH based
on lung sizes, position of the liver and pulmonary vascu-
lature status6,8–20. However, as yet there is no consensus
as to which parameter is most accurate and useful in
predicting neonatal outcome in these cases.
In this study, therefore, we evaluated prospectively dif-
ferent ultrasound parameters in 108 fetuses with isolated
CDH in order to analyze the accuracy and the probability
of each parameter to predict postnatal survival and severe
PAH, providing a basis for classifying the cases according
to the severity of CDH. Our series underwent neither fetal
surgery nor termination of pregnancy.
PATIENTS AND METHODS
Between January 2004 and December 2010, we con-
ducted a prospective observational study in our tertiary
Fetal Medicine Unit, evaluating 108 fetuses with isolated
CDH (82 left-sided and 26 right-sided). Inclusion crite-
ria were: (1) gestational age established by last menstrual
period in accordance with first-/second-trimester ultra-
sonography; (2) confirmed ultrasound diagnosis of CDH;
(3) normal fetal karyotype; (4) absence of other struc-
tural anomalies; (5) no fetal surgery. The protocol was
approved by the local ethics committee. The pregnant
patients were informed that the results of the study would
not be used to modify their perinatal management. The
perinatologists, ultrasonographers and surgeons in charge
were unaware of the results of the lung volume mea-
surements. Termination of pregnancy was not performed
since it is not permitted in our country.
Fetal lung parameters
Using a Voluson 730 (GE Healthcare, Zipf, Austria) ultra-
sound machine we evaluated between 26 and 30 weeks
the following fetal lung parameters: (1) side of the
diaphragmatic defect (left or right); (2) presence of poly-
hydramnios (amniotic fluid index > 25 cm); (3) presence
of fetal liver herniated into the fetal thorax (‘liver-
up’); (4) LHR; (5) observed/expected LHR (o/e-LHR);
(6) observed/expected contralateral fetal lung volume
(o/e-ContFLV) ratio; (7) observed/expected total fetal
lung volume (o/e-TotFLV) ratio; (8) ultrasonographic
fetal lung volume/fetal weight ratio (US-FLW); (9)
observed/expected contralateral pulmonary artery dia-
meter (o/e-ContPA) ratio; (10) observed/expected main
pulmonary artery diameter (o/e-MPA) ratio; and (11)
contralateral vascularization index (Cont-VI). In addi-
tion, the following data were evaluated: (12) gestational
age at diagnosis; (13) gestational age at birth; and (14)
newborn weight.
The LHR was measured using two-dimensional
(2D) ultrasonography by multiplying the two longest
perpendicular diameters of the contralateral lung at the
level of the four-chamber view of the heart and dividing
this by the head circumference (measured in mm)21,22.
We calculated o/e-LHR by comparing the LHR with the
expected value for gestational age on 2D ultrasound6,23.
We determined o/e-ContFLV and o/e-TotFLV by esti-
mating the contralateral and total lung volumes, respec-
tively, using Virtual Organ Computer-aided AnaLysis
(VOCAL
TM
) software (Sonoview software, GE Health-
care), rotating the three-dimensional (3D) image 30◦
degrees as described previously16,20, and comparing them
to the expected values for gestational age24,25. US-FLW
was the ratio between total fetal lung volume as estimated
by 3D ultrasound and the estimated fetal weight using the
Hadlock equation, which has been demonstrated not to
vary throughout gestational age19. Fetal lung sizes were
represented by LHR, o/e-LHR, o/e-ContFLV, o/e-TotFLV
and US-FLW.
The o/e-ContPA and the o/e-MPA were evaluated by
measuring the contralateral and the main pulmonary
artery diameters on a cross-sectional image of the fetal
chest at the level of the three vessels (main pulmonary
artery, ascending aorta and superior vena cava) in the
short-axis view of the fetal heart18,26, and comparing
them to the expected values for gestational age27. Cont-VI
was calculated using the 3D power Doppler histogram as
reported previously17 and using the same power Doppler
presets (angio mode, cent; smooth, 4/5; frequency, low;
quality, 16; density, 6; enhance, 16; balance, G> 150; fil-
ter, 2; actual power, 2 dB; pulse repetition frequency, 0.9).
The 3D volume of the fetal thorax was acquired and the
contralateral lung volume was measured in the transverse
plane using VOCAL
TM
software (rotation of 30◦ degrees).
A 3D power Doppler histogram was used to determine
the vascularization index (VI) from inbuilt computer algo-
rithms which calculate the color voxel to total voxel ratio.
This percentage of color flow Doppler within the lung is
indicative of the vessels that are present as compared
with the background non-vascular parenchyma. Since it
has been demonstrated previously that fetal pulmonary
VI does not vary throughout gestation17, an observed-to-
expected ratio was unnecessary for this parameter. Fetal
pulmonary vasculature was evaluated by the pulmonary
artery diameters (o/e-ContPA and o/e-MPA) and Cont-VI.
Perinatal management
All fetuses with prenatal diagnosis of isolated CDH were
followed in our Fetal Medicine Unit and were delivered in
our Children’s Hospital. All babies were treated following
the same protocol28. Briefly, the neonates were intubated
in the delivery room and admitted immediately to the
neonatal intensive care unit. Immediate ventilator support
was initiated in all cases, with high-frequency oscilla-
tory ventilation when necessary, followed by delayed
CDH repair in all cases. The treatment protocol did not
include extracorporeal membrane oxygenation (ECMO),
either pre- or postoperatively, as this treatment modality
is not available at our institution. Inhaled nitric oxide
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(iNO) was administered in cases of persistent PAH
verified by a pre- vs postductal saturation difference
of > 10%, confirmed by echocardiography. Hemody-
namic support was achieved by volume expansion and
administration of dobutamine (10–20 µg/kg/min) and
norepinephrine (0.5–2 µg/kg/min) when necessary. Pre-
operative respiratory and hemodynamic stabilization,
required before delayed CDH repair was performed, was
defined by the following criteria: (a) normal hemody-
namic variables (mean blood pressure > 40 mmHg with
urine output > 2 mL/kg/h) without need for inotropic
agents; (b) absence of PAH after discontinuation of iNO;
(c) successful weaning to conventional mechanical venti-
lation with moderate values of peak inspiratory pressure
(15–20 cmH2O) and adequate oxygenation, achieved
with FiO2 ≤ 40%.
Outcomes and statistical analysis
The primary outcome was neonatal survival to 28 days.
The secondary outcome was postnatal diagnosis of severe
PAH. Severe PAH was considered when the neonate pre-
sented with profound cyanosis associated with echocar-
diographic continuous right-to-left shunting through a
persistent ductus arteriosus and a persistent difference in
pre- to postductal saturation gradient > 20%, despite the
use of iNO29.
Data were analyzed using Student’s t and chi-square
tests to evaluate the association of the ultrasound para-
meters with neonatal survival and with postnatal diagno-
sis of severe PAH. Correlations between variables were
evaluated by Pearson test. Receiver–operating character-
istics (ROC) curves were also calculated to evaluate the
accuracy of each variable in the prediction of neonatal
survival and postnatal diagnosis of severe PAH, by com-
paring the areas under the curves (AUCs). Best cut-offs
(points with the highest sensitivity and lowest rate of false
positivity) were then established. The accuracy of each
ultrasound parameter to predict both outcomes was calcu-
lated using the best cut-off obtained from the ROC curve
analysis using the following equation: accuracy = (num-
ber of true positives + number of true negatives)/total
number of measurements. Statistical comparison between
the accuracies of ultrasound parameters was performed
using McNemar and Cochran’s Q tests (SPSS for Win-
dows version 17; Microsoft Corp., Chicago, IL, USA).
Statistical comparisons between the AUCs of different
ultrasound variables were also performed according to
the DeLong et al. and Hanley & McNeil tests (Med-
Calc software version 11.6, Mariakerke, Belgium)30–32.
The probabilities for the events (neonatal survival and
severe PAH) based on each ultrasound parameter were
also calculated using regression. Based on the proba-
bilities of neonatal survival and postnatal diagnosis of
PAH, a prognostic classification of CDH was established
(Statistica, version 9, StatSoft Inc., Tulsa, OK, USA). Mul-
tivariable studies were performed using logistic regression
and factor analysis (SPSS for Windows version 17). Sta-
tistical differences were considered to be significant when
P < 0.05.
RESULTS
The neonatal mortality rate in our series was 64.8%
(70/108). All survivors were doing well at 6 months.
Severe PAH was diagnosed postnatally in 68 (63.0%)
cases, and this was statistically associated with neonatal
death: 92.6% (63/68) newborns with severe PAH died
while 15.0% (7/40) infants without severe PAH died
(P < 0.001).
Table 1 presents the prenatal characteristics accord-
ing to neonatal outcome. Liver herniation into the fetal
thorax (liver-up), the ultrasonographic parameters rep-
resenting fetal lung size (LHR, o/e-LHR, o/e-ContFLV,
o/e-TotFLV and US-FLW), fetal pulmonary diameters
(o/e-ContPA and o/e-MPA) and contralateral lung vas-
cularization (Cont-VI) were statistically associated with
either neonatal death or postnatal severe PAH (P < 0.05).
Gestational age at diagnosis, polyhydramnios, side of
defect, gestational age at birth and birth weight were
related to neither neonatal survival nor postnatal diagno-
sis of severe PAH in this series.
With the exception of o/e-LHR and US-FLW, all fetal
ultrasonographic lung parameters correlated statistically
with each other (Table S1). The ROC curves used
to determine the best cut-offs and accuracies for each
ultrasound parameter in the prediction of postnatal
death and severe PAH are presented in Figure 1, and
the accuracies themselves are given in Tables S2 and
S3. Considering the parameters representing fetal lung
size, those evaluating total lung volumes had greater
accuracy than did those evaluating only the contralateral
lung, based on the AUCs and the comparison between
accuracies (McNemar and Cochran’s Q tests, P < 0.01).
The o/e-TotFLV had the highest accuracy to predict
both neonatal death and severe PAH (83.3% and
86.1%, respectively) when compared with LHR (73.1%
and 78.7%, P < 0.01), o/e-LHR (75.9% and 72.2%;
P = 0.07) and o/e-ContFLV (75.0% and 78.7%; P =
0.02), but o/e-TotFLV was not superior to US-FLW
(80.6% and 75.9%; P = 0.59) and liver-up (79.6%
and 74.1%, P = 0.41). However, Cont-VI was the best
ultrasound parameter in predicting postnatal death and
severe postnatal PAH (88.9% and 91.7%, respectively,
P < 0.001), being more accurate than all other ultrasound
parameters.
The relative risks (RR) of each parameter for the out-
comes are also shown in Tables S2 and S3. Based on this
information, for each ultrasound parameter it was possi-
ble to determine the risks for outcomes in isolated CDH.
For example, fetuses with o/e-TotFLV < 0.35 have an
approximately four times higher risk of death and post-
natal severe PAH than do those with o/e-TotFLV ≥ 0.35
(RR, 5.2 (95% CI, 2.5–11.0) and RR, 3.7 (95% CI,
2.2–6.4), respectively). The probabilities of each parame-
ter to predict neonatal death or survival were calculated,
leading to mathematical equations presented in Tables S2
and S3, respectively.
A further analysis was performed considering differ-
ent combinations of parameters, including one parameter
Copyright  2011 ISUOG. Published by John Wiley & Sons, Ltd. Ultrasound Obstet Gynecol 2012; 39: 42–49.
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Table 1 Prenatal findings of 108 fetuses with isolated congenital diaphragmatic hernia (CDH), according to neonatal outcome
Neonatal death Severe PAH
All cases
Finding (n = 108) Yes (n = 70) No (n = 38) P Yes (n = 68) No (n = 40) P
GA at diagnosis (weeks) 20.6 ± 5.1 20.1 ± 5.2 20.7 ± 4.7 0.84 20.7 ± 5.2 20.3 ± 4.8 0.72
Laterality of CDH 0.13 0.09
Left-sided 82 (75.9) 50 (71.4) 32 (84.2) 48 (70.6) 34 (85.0)
Right-sided 26 (24.1) 20 (28.6) 6 (15.8) 20 (29.4) 6 (15.0)
Polyhydramnios 37 (34.3) 23 (32.5) 14 (36.8) 0.812 25 (36.8) 12 (30.0) 0.477
LHR 1.40 ± 0.88 0.97 ± 0.31 2.19 ± 1.06 < 0.001 1.0 ± 0.7 1.9 ± 0.9 < 0.001
o/e-LHR (%) 24.3 ± 8.5 20.5 ± 6.5 31.3 ± 7.2 < 0.001 21.5 ± 8.0 28.9 ± 7.4 < 0.001
Liver-up 76 (70.4) 62 (88.6) 14 (36.8) < 0.001 58 (85.3) 18 (45.0) < 0.001
o/e-ContFLV 0.52 ± 0.16 0.45 ± 0.10 0.67 ± 0.15 < 0.001 0.47 ± 0.13 0.61 ± 0.16 < 0.001
o/e-TotFLV 0.33 ± 0.13 0.26 ± 0.07 0.45 ± 0.12 < 0.001 0.28 ± 0.11 0.40 ± 0.12 < 0.001
US-FLW 0.011 ± 0.008 0.009 ± 0.001 0.014 ± 0.003 0.005 0.010 ± 0.002 0.013 ± 0.004 0.01
o/e-ContPA 0.71 ± 0.13 0.66 ± 0.13 0.79 ± 0.08 < 0.001 0.66 ± 0.13 0.78 ± 0.08 < 0.001
o/e-MPA 0.82 ± 0.18 0.75 ± 0.16 0.95 ± 0.11 < 0.001 0.75 ± 0.17 0.95 ± 0.11 < 0.001
Cont-VI 19.9 ± 11.9 13.4 ± 5.4 31.9 ± 11.3 < 0.001 13.4 ± 5.00 30.94 ± 12.12 < 0.001
GA at birth (weeks) 37.3 ± 1.9 37.2 ± 1.3 37.3 ± 1.7 0.93 37.3 ± 1.7 37.2 ± 1.2 0.86
Birth weight (g) 3016.2 ± 469.7 2995.7 ± 405.8 3067.7 ± 482.2 0.55 3084.1 ± 474.1 2966.9 ± 443.9 0.32
Data given as mean ± SD or n (%). ContFLV, contralateral fetal lung volume ratio; ContPA, contralateral pulmonary artery diameter ratio;
Cont-VI, vascularization index of the contralateral lung; GA, gestational age; LHR, lung-to-head ratio; Liver-up, > 1/3 of liver herniated
into the fetal thorax; MPA, main pulmonary artery diameter ratio; o/e, observed/expected; PAH, pulmonary arterial hypertension; TotFLV,




























Figure 1 Receiver–operating characteristics curves for the prediction of neonatal death (a) and postnatal severe pulmonary arterial
hypertension (b) using different lung parameters: , LHR; , o/e-LHR; , o/e-TotFLV; , o/e-ContFLV; , US-FLW;
, o/e-MPA; , o/e-ContPA; , Cont-VI; , Reference line. (LHR, lung-to-head ratio; ContFLV, contralateral fetal lung
volume; ContPA, contralateral pulmonary artery diameter; Cont-VI, vascularization index of the contralateral lung; MPA, main pulmonary
artery diameter; o/e, observed/expected; TotFLV, total fetal lung volume; US-FLW, ultrasonographic fetal lung volume/fetal weight).
that measures lung size (LHR, o/e-LHR, o/e-ContFLV,
o/e-TotFLV or US-FLW) and the presence/absence of liver
herniation, and one parameter that measures pulmonary
vascularity (Cont-VI or o/e-MPA). ROC curves of the
combined variables are shown in Figure 2 and results are
presented in Tables S4 and S5. There was no statistically
significant difference between these different combina-
tions for the prediction of neonatal survival or postnatal
diagnosis of severe PAH (P > 0.05).
Based on the probability estimations of neonatal
survival and postnatal diagnosis of PAH using these
ultrasound parameters (Tables S2–S5), isolated CDH
could be classified into four groups: extremely severe,
severe, moderate and mild (Table 2). In our present series,
the vast majority (almost 50%) of cases had severe CDH.
DISCUSSION
Many different methods have been proposed to esti-
mate fetal lung size6,13,21,22,33–35. The method used most
widely is LHR, which is an uncomplicated means of
measuring the contralateral lung size. However, some
authors have suggested that LHR may vary throughout
gestation34,36,37, and so o/e-LHR was proposed, which
Copyright  2011 ISUOG. Published by John Wiley & Sons, Ltd. Ultrasound Obstet Gynecol 2012; 39: 42–49.




























Figure 2 Receiver–operating characteristics curves for the prediction of neonatal death (a) and postnatal severe pulmonary arterial
hypertension (b) using the combination of different lung parameters: , LHR+Liver-up+Cont-VI; , o/e-LHR+Liver-up+Cont-VI;
, o/e-ContFLV+Liver-up+Cont-VI; , o/e-TotFLV+Liver-up+Cont-VI; , US-FLW+Liver-up+Cont-VI; ,
LHR+Liver-up+o/e-MPA; , o/e-LHR+Liver-up+o/e-MPA; , o/e-ContFLV+Liver-up+o/e-MPA; ,
o/e-TotFLV+Liver-up+o/e-MPA; , US-FLW+Liver-up+o/e-MPA; , Reference line. (LHR, lung-to-head ratio; ContFLV,
contralateral fetal lung volume; Cont-VI, vascularization index of the contralateral lung; Liver-up, > 1/3 of liver herniated into the fetal
thorax; MPA, main pulmonary artery diameter; o/e, observed/expected; TotFLV, total fetal lung volume; US-FLW, ultrasonographic fetal
lung volume/fetal weight).
Table 2 Classification and ultrasonographic parameters of 108 fetuses with isolated congenital diaphragmatic hernia (CDH), based on their
probabilities of surviving and of having severe pulmonary arterial hypertension (PAH)*
Prenatal classification of CDH
Parameter Extremely severe Severe Moderate Mild
Probability of survival (%, mean (range)) 5 (0–10) 15 (10–30) 50 (30–80) 90 (80–100)
Probability of severe PAH (%, mean (range)) > 70.0 60 (50–70) 45 (20–50) < 20
Classification (n (%)) 11 (10.2) 48 (44.4) 30 (27.8) 19 (17.6)
LHR < 0.70 0.70–1.14 1.15–1.90 > 1.90
o/e-LHR (%) < 15 15–26 27–45 > 45
o/e-ContFLV < 0.48 0.48–0.51 0.52–0.60 > 0.60
o/e-TotFLV < 0.29 0.29–0.31 0.32–0.39 > 0.39
US-FLW < 0.009 0.009–0.010 0.011–0.013 > 0.013
o/e-ContPA < 0.66 0.66–0.70 0.71–0.85 > 0.85
o/e-MPA < 0.75 0.75–0.81 0.82–1.02 > 1.02
Cont-VI < 15 15–18 19–28 > 28
Data given as range unless stated otherwise. *Probabilities estimated from equations in Tables S2–S5. ContFLV, contralateral fetal lung
volume; ContPA, contralateral pulmonary artery diameter; Cont-VI, vascularization index of the contralateral lung; LHR, lung-to-head
ratio; MPA, main pulmonary artery diameter; o/e, observed/expected; TotFLV, total fetal lung volume; US-FLW, ultrasonographic fetal lung
volume/fetal weight.
is adjusted according to gestational age6,38. These two
methods use 2D ultrasound technology. In our present
study, the gestational age at ultrasound examination
did not vary considerably (from 26 to 30 weeks), so
it is possible that LHR did not vary much within this
narrow age range. Fetal lung volumes can be mea-
sured using magnetic resonance imaging (MRI) or 3D
ultrasound10,13,14,20,35,39–42. Since fetal lung volumes vary
throughout gestation, they should be adjusted either to
expected values according to gestational age or to esti-
mated fetal weight19,20. It has been demonstrated that
the lung ipsilateral to the diaphragmatic defect is more
hypoplastic than is the contralateral one, which suggests
that evaluation of both lungs may better estimate the
degree of pulmonary hypoplasia in isolated CDH14–16,43.
We found that measuring total lung volumes (o/e-TotFLV
and US-FLW) predicted neonatal outcome more accu-
rately than did using the contralateral lung measurements
(LHR, o/e-LHR and o/e-ContFLV).
Fetal pulmonary vascularity in isolated CDH can be
evaluated by measuring pulmonary artery diameters on
2D ultrasound, studying pulmonary arterial flow using
2D color Doppler or estimating the vascular indices using
3D power Doppler ultrasonography18,26,44,45. Our study
confirmed that evaluation of fetal pulmonary vasculature
is useful in the prediction of severe PAH and therefore
of neonatal death. The better prediction of neonatal out-
comes in isolated CDH by the VI compared with the
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pulmonary arterial diameters may be explained by the
fact that the VI evaluates the vascularity of an entire
organ (pulmonary function) while the PA diameters may
be more related to pulmonary vessel and lung size.
In this study, we established mathematical equations
to calculate the probabilities of the events (neonatal
survival/death and severe PAH) by using ultrasound
parameters associated with neonatal outcome. Based on
these equations, fetuses with isolated CDH were classi-
fied according to the prognosis into four groups: those
with extremely severe, severe, moderate and mild CDH.
The importance of classifying CDH according to severity
is that this can be used to guide perinatal management.
Fetuses with mild CDH have more than an 80% chance
of survival and less than a 20% chance of presenting
with severe postnatal PAH, while those with moderate
CDH have an approximately 50% chance for each. In
both of these cases, postnatal therapy in a specialized
center is recommended, while fetal intervention is not.
For severe CDH, with an approximately 15% chance of
survival and higher than 60% chance of presenting with
PAH, fetal tracheal occlusion has been proposed as a
therapeutic option46,47. Our initial study demonstrated a
potential benefit for fetal tracheal occlusion in severe CDH
by improving the survival rate from 5% in non-treated
fetuses to 50% after fetal intervention46, and these find-
ings have been recently confirmed in a randomized trial48.
Another therapeutic option for severe CDH is the use of
ECMO. However, the benefits of ECMO in such cases
need to be evaluated.
This classification also allows comparison of neonatal
mortality rates between different centers by matching for
severity of the CDH. For example, in our present series,
the mortality rate was extremely high (64.8%) when
compared with other centers6,49,50. However, a large pro-
portion (54.6%) of cases in our series had severe or
extremely severe CDH. This can be explained by the fact
that in our series there were no terminations of pregnancy
or fetal interventions. Furthermore, this series represents
cases diagnosed prenatally, many of which were referred
to our center due to their severity because we offer fetal
therapy for severe CDH (on a referral bias).
In our study, fetuses with right and left CDH were ana-
lyzed together since the aim of the present study was to
evaluate whether right-sided CDH had worse prognosis
than left-sided defect. However, our results demonstrated
that right-sided CDH was not associated statistically with
poor neonatal outcome, which is not in accordance with
other studies47,51. In our opinion, the herniated liver,
reduced lung sizes and decreased vascularity are factors
related directly to the neonatal outcomes in isolated CDH
independent of the side of the defect. Perhaps previous
studies did not consider this fact and the right-sided CDH
was considered to have poor prognosis, but in reality
these cases had liver herniated into fetal thorax, reduced
lung sizes and decreased pulmonary vascularity.
In conclusion, neonatal outcome in fetuses with isolated
CDH can be predicted by evaluating the lung size,
confirming a herniated liver and analyzing the pulmonary
vasculature. Measuring the total lung volumes (o/e-
TotFLV) more accurately predicts neonatal outcome than
does measuring only the contralateral lung size (LHR,
o/e-LHR and o/e-ContFLV). The prediction of neonatal
outcome is more accurate by evaluating the pulmonary
vasculature using the VI on 3D power Doppler ultrasound,
since it is related more to the postnatal diagnosis of
severe PAH, which may be the main cause of death in
newborns with isolated CDH. The present study provides
mathematical equations to calculate the probabilities of
survival/death and severe PAH, which allows classification
of affected fetuses according to severity of CDH.
This suggested classification may guide the perinatal
management of fetuses with isolated CDH and may allow
a better comparison between results in different centers.
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SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Table S1 Correlations between ultrasonographic parameters in 108 fetuses with isolated CDH
Table S2 Prediction of neonatal death using multiple ultrasound parameters in 108 fetuses with
CDH
Table S3 Prediction of severe PAH using multiple ultrasound parameters in 108 fetuses with CDH
Table S4 Prediction of neonatal death using the combination of multiple ultrasound parameters
in 108 fetuses with CDH
Table S5 Prediction of severe pulmonary arterial hypertension using the combination of multiple ultrasound
parameters in 108 fetuses with CDH
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